SMS LIFESCIENCES INDIA
|
SMS LIFESCIENCES INDIA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 37.91 | 83.76 | 44.84 | 33.68 | 59.03 |
| CEPS(Rs) | 73.32 | 116.78 | 70.84 | 59.69 | 80.14 |
| DPS(Rs) | 1.50 | 1.50 | 1.50 | - | 1.50 |
| Book NAV/Share(Rs) | 557.71 | 503.53 | 427.40 | 382.80 | 351.70 |
| Tax Rate(%) | 31.43 | 22.70 | 30.72 | 30.58 | 29.69 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 8.05 | 8.88 | 10.25 | 8.74 | 8.35 |
| EBIT Margin(%) | 6.55 | 10.02 | 8.19 | 6.82 | 7.42 |
| Pre Tax Margin(%) | 4.63 | 8.42 | 6.63 | 5.05 | 6.10 |
| PAT Margin (%) | 3.18 | 6.51 | 4.59 | 3.51 | 4.29 |
| Cash Profit Margin (%) | 6.19 | 9.08 | 7.26 | 6.21 | 5.82 |
| Performance Ratios | |||||
| ROA(%) | 2.98 | 7.54 | 4.82 | 3.83 | 6.45 |
| ROE(%) | 7.09 | 17.98 | 11.07 | 9.17 | 16.78 |
| ROCE(%) | 9.44 | 18.42 | 12.96 | 11.91 | 20.14 |
| Asset Turnover(x) | 0.94 | 1.16 | 1.05 | 1.09 | 1.51 |
| Sales/Fixed Asset(x) | 1.59 | 2.28 | 1.88 | 2.04 | 3.07 |
| Working Capital/Sales(x) | 14.02 | 18.89 | 24.17 | 14.39 | 24.07 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.63 | 0.44 | 0.53 | 0.49 | 0.33 |
| Receivable days | 40.71 | 31.92 | 34.48 | 39.53 | 36.22 |
| Inventory Days | 87.15 | 68.75 | 77.87 | 91.38 | 71.14 |
| Payable days | 146.47 | 135.85 | 154.56 | 169.86 | 139.67 |
| Valuation Parameters | |||||
| PER(x) | 13.71 | 8.30 | 11.04 | 5.20 | 9.35 |
| PCE(x) | 7.09 | 5.95 | 6.99 | 2.93 | 6.89 |
| Price/Book(x) | 0.93 | 1.38 | 1.16 | 0.46 | 1.57 |
| Yield(%) | 0.29 | 0.22 | 0.30 | - | 0.27 |
| EV/Net Sales(x) | 0.80 | 0.81 | 0.76 | 0.42 | 0.56 |
| EV/Core EBITDA(x) | 7.88 | 7.80 | 6.33 | 3.94 | 5.67 |
| EV/EBIT(x) | 10.72 | 7.26 | 8.39 | 5.50 | 6.84 |
| EV/CE(x) | 0.63 | 0.78 | 0.66 | 0.43 | 0.76 |
| M Cap / Sales | 0.50 | 0.60 | 0.56 | 0.20 | 0.44 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -9.86 | 31.81 | 1.84 | -30.98 | - |
| Core EBITDA Growth(%) | -12.07 | 13.25 | 15.71 | -25.74 | - |
| EBIT Growth(%) | -39.78 | 61.21 | 21.94 | -35.85 | - |
| PAT Growth(%) | -55.03 | 86.62 | 33.13 | -42.94 | - |
| EPS Growth(%) | -54.73 | 86.79 | 33.13 | -42.94 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.59 | 0.51 | 0.50 | 0.55 | 0.44 |
| Current Ratio(x) | 1.19 | 1.14 | 1.10 | 1.22 | 1.13 |
| Quick Ratio(x) | 0.56 | 0.55 | 0.58 | 0.51 | 0.51 |
| Interest Cover(x) | 3.42 | 6.26 | 5.26 | 3.85 | 5.61 |
| Total Debt/Mcap(x) | 0.63 | 0.37 | 0.43 | 1.20 | 0.28 |
Compare Financial Ratios of peers of SMS LIFESCIENCES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS LIFESCIENCES INDIA | ₹201.1 Cr | -0.3% | 0.7% | 18.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
| CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics | |
SMS LIFESCIENCES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS LIFESCIENCES INDIA | -0.3% |
0.7% |
18.5% |
| SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses
